The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma

Open Access

Peer-reviewed

Research Article

Kirsty Wienand,

Affiliation Division of Haematology, University of Cape Town, Cape Town, South Africa
⨯
Karen Shires

* E-mail: karen.shires@uct.ac.za

Affiliations Division of Haematology, University of Cape Town, Cape Town, South Africa, Division of Haematology, National Health Laboratory Services/Groote Schuur Hospital, Cape Town, South Africa
⨯

Reader Comments (0)

B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Plasma cells
Is the Subject Area "Plasma cells" applicable to this article?

Thanks for your feedback.
Neoplastic transformation
Is the Subject Area "Neoplastic transformation" applicable to this article?

Thanks for your feedback.
Hematologic cancers and related disorders
Is the Subject Area "Hematologic cancers and related disorders" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Phenotypes
Is the Subject Area "Phenotypes" applicable to this article?

Thanks for your feedback.